Methylene blue is used to treat which condition?

Methylene blue is used to treat which condition?

• A. Methemoglobinemia
• B. Cyanide toxicity
• C. Propofol infusion syndrome
• D. Hyperkalemia

Answer: (A)

Methemoglobinemia is caused by iron in hemoglobin being in the ferric (Fe3+) state, which cannot bind and release oxygen effectively, leading to functional hypoxia even if arterial oxygen is normal. Methylene blue treats this by serving as an artificial electron carrier: it is reduced by Nadph-dependent methemoglobin reductase to leucomethylene blue, which then donates electrons to methemoglobin, converting the ferric iron back to the ferrous (Fe2+) state and restoring normal oxygen carrying. This is why methylene blue is the specific antidote for methemoglobinemia. Dose is typically 1–2 mg/kg IV over a few minutes, with a possible repeat if needed, but it should be used cautiously in G6PD deficiency due to risk of hemolysis and in patients on serotonergic medications due to potential interactions. It is not appropriate for cyanide toxicity, which is treated with nitrites or hydroxocobalamin, nor for conditions like propofol infusion syndrome or hyperkalemia, which require other management strategies.

Methemoglobinemia is caused by iron in hemoglobin being in the ferric (Fe3+) state, which cannot bind and release oxygen effectively, leading to functional hypoxia even if arterial oxygen is normal. Methylene blue treats this by serving as an artificial electron carrier: it is reduced by Nadph-dependent methemoglobin reductase to leucomethylene blue, which then donates electrons to methemoglobin, converting the ferric iron back to the ferrous (Fe2+) state and restoring normal oxygen carrying. This is why methylene blue is the specific antidote for methemoglobinemia.

Dose is typically 1–2 mg/kg IV over a few minutes, with a possible repeat if needed, but it should be used cautiously in G6PD deficiency due to risk of hemolysis and in patients on serotonergic medications due to potential interactions. It is not appropriate for cyanide toxicity, which is treated with nitrites or hydroxocobalamin, nor for conditions like propofol infusion syndrome or hyperkalemia, which require other management strategies.